Susquehanna International Group
IMNM icon

Susquehanna International Group’s Immunome IMNM Stock Holding History

Susquehanna International Group’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.29M Sell
58,985
-111,929
-65% -$2.49M ﹤0.01% 7248
2025
Q4 		$3.67M Buy
170,914
+100,749
+144% +$1.77M ﹤0.01% 4539
2025
Q3 		$822K Sell
70,165
-64,997
-48% -$647K ﹤0.01% 7814
2025
Q2 		$1.26M Sell
135,162
-1,241,891
-90% -$10.2M ﹤0.01% 6860
2025
Q1 		$9.27M Buy
1,377,053
+1,294,458
+1,567% +$12.4M ﹤0.01% 2627
2024
Q4 		$877K Buy
82,595
+30,964
+60% +$374K ﹤0.01% 7294
2024
Q3 		$755K Buy
51,631
+21,920
+74% +$311K ﹤0.01% 7474
2024
Q2 		$360K Sell
29,711
-289,803
-91% -$4.53M ﹤0.01% 9058
2024
Q1 		$7.89M Buy
319,514
+284,687
+817% +$5.78M ﹤0.01% 2963
2023
Q4 		$373K Buy
34,827
+9,698
+39% +$80.6K ﹤0.01% 9355
2023
Q3 		$210K Buy
25,129
+7,665
+44% +$56.3K ﹤0.01% 10129
2023
Q2 		$138K Buy
17,464
+4,913
+39% +$26.9K ﹤0.01% 10661
2023
Q1 		$62.6K Sell
12,551
-9,513
-43% -$46.5K ﹤0.01% 11593
2022
Q4 		$48.5K Buy
+22,064
New +$88.9K ﹤0.01% 11414
2022
Q3 		– Sell
-12,052
Closed -$56.5K – 13625
2022
Q2 		$39K Sell
12,052
-21,715
-64% -$79K ﹤0.01% 12105
2022
Q1 		$192K Sell
33,767
-31,682
-48% -$237K ﹤0.01% 11283
2021
Q4 		$848K Buy
65,449
+6,568
+11% +$117K ﹤0.01% 7732
2021
Q3 		$1.43M Buy
+58,881
New +$1.03M ﹤0.01% 6605

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Susquehanna International Group's IMNM Position: Q1 2026 in Review

Susquehanna International Group reduced its Immunome (IMNM) stake by 65% in Q1 2026, selling an estimated $2.49M and leaving 58,985 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #7248.

Susquehanna International Group first reported a position in IMNM in Q3 2021 and has held it in 18 quarters since. The position peaked at $9.27M in Q1 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Susquehanna International Group held 58,985 shares of Immunome worth $1.29M as of Q1 2026.
  • Susquehanna International Group sold 111,929 Immunome shares in Q1 2026, an estimated $2.49M.
  • Immunome made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7248 holding.
  • Susquehanna International Group first reported a position in Immunome in Q3 2021 and has held it in 18 quarters since.
  • Susquehanna International Group's Immunome position peaked at $9.27M in Q1 2025.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.